Skip to main content
. 2017 Mar 17;8(23):37308–37320. doi: 10.18632/oncotarget.16307

Table 6. Associations of the PPARGC1A rs3736265 G>A genetic variants with biochemistry characteristics among control participants.

Genotype Controls (n=782) FPG (mmol/L) P Total cholesterol (mmol/L) P Triglyceride (mmol/L) P HDL-C (mmol/L) P LDL-C (mmol/L) P
n %
GG 557 71.41 5.16±0.47 1.0 4.87±1.02 1.0 1.52±0.93 1.0 1.29±0.35 1.0 3.14±0.82 1.0
GA 196 25.13 5.04±0.50 0.002 4.88±1.00 0.878 1.57±0.97 0.507 1.33±0.39 0.238 3.11±0.79 0.704
AA 27 3.46 5.21±0.66 0.601 5.10±1.22 0.249 1.97±0.95 0.014 1.27±0.46 0.695 3.34±0.92 0.220
GA + AA 223 28.59 5.06±0.53 0.009 4.91±1.03 0.624 1.62±0.97 0.179 1.32±0.40 0.337 3.14±0.81 0.980
GG+GA 753 96.54 5.13±0.48 1.0 4.87±1.01 1.0 1.53±0.94 1.0 1.30±0.36 1.0 3.13±0.81 1.0
AA 27 3.46 5.21±0.66 0.395 5.10±1.22 0.249 1.97±0.95 0.017 1.27±0.46 0.606 3.34±0.92 0.197

FPG: fasting plasma glucose;

HDL-C, high-density lipoprotein cholesterol;

LDL-C, low-density lipoprotein cholesterol;

Bold values are statistically significant (P <0.05)